Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Porter

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
World Journal of Urology|July 22, 2022
Comparison of perioperative outcomes following transperitoneal versus retroperitoneal robot-assisted partial nephrectomy: a propensity-matched analysis of VCQI databaseGopal Sharma, Milap Shah, Puneet Ahluwalia, et al.
World Journal of Urology|October 6, 2022
Perioperative outcomes following robot-assisted partial nephrectomy in elderly patientsGopal Sharma, Milap Shah, Puneet Ahluwalia, et al.
Indian Journal of Urology : IJU : Journal of the Urological Society of India|December 26, 2022
Perioperative outcomes following robot-assisted partial nephrectomy for complex renal masses: A Vattikuti Collective Quality Initiative database studyGopal Sharma, Milap Shah, Puneet Ahluwalia, et al.
Journal of Robotic Surgery|May 29, 2023
Robot-assisted partial nephrectomy in morbidly obese patients: a VCQI database studyGopal Sharma, Gurpremjit Singh, Puneet Ahluwalia, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90Jens R Sydor, Emmanuel Normant, Christine S Pien, et al.
Journal of Medicinal Chemistry|October 10, 2008
Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonistsMartin R Tremblay, Marta Nevalainen, Somarajan J Nair, et al.
BJU International|April 22, 2020
Predicting intra-operative and postoperative consequential events using machine-learning techniques in patients undergoing robot-assisted partial nephrectomy: a Vattikuti Collective Quality Initiative database studyMahendra Bhandari, Anubhav Reddy Nallabasannagari, Madhu Reddiboina, et al.
European Urology Focus|November 17, 2024
Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter StudyAlireza Ghoreifi, Farshad Sheybaee Moghaddam, Anirban P Mitra, et al.
Cancer Discovery|December 13, 2022
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance MutationsAlexander Drilon, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Cancer Discovery|September 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound MutationsJessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
World Journal of Urology|July 22, 2022
Comparison of perioperative outcomes following transperitoneal versus retroperitoneal robot-assisted partial nephrectomy: a propensity-matched analysis of VCQI databaseGopal Sharma, Milap Shah, Puneet Ahluwalia, et al.
World Journal of Urology|October 6, 2022
Perioperative outcomes following robot-assisted partial nephrectomy in elderly patientsGopal Sharma, Milap Shah, Puneet Ahluwalia, et al.
Indian Journal of Urology : IJU : Journal of the Urological Society of India|December 26, 2022
Perioperative outcomes following robot-assisted partial nephrectomy for complex renal masses: A Vattikuti Collective Quality Initiative database studyGopal Sharma, Milap Shah, Puneet Ahluwalia, et al.
Journal of Robotic Surgery|May 29, 2023
Robot-assisted partial nephrectomy in morbidly obese patients: a VCQI database studyGopal Sharma, Gurpremjit Singh, Puneet Ahluwalia, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90Jens R Sydor, Emmanuel Normant, Christine S Pien, et al.
Journal of Medicinal Chemistry|October 10, 2008
Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonistsMartin R Tremblay, Marta Nevalainen, Somarajan J Nair, et al.
BJU International|April 22, 2020
Predicting intra-operative and postoperative consequential events using machine-learning techniques in patients undergoing robot-assisted partial nephrectomy: a Vattikuti Collective Quality Initiative database studyMahendra Bhandari, Anubhav Reddy Nallabasannagari, Madhu Reddiboina, et al.
European Urology Focus|November 17, 2024
Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter StudyAlireza Ghoreifi, Farshad Sheybaee Moghaddam, Anirban P Mitra, et al.
Cancer Discovery|December 13, 2022
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance MutationsAlexander Drilon, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Cancer Discovery|September 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound MutationsJessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Pageof 6